Semaglutide Treatment, Appetite, and Eating Behavior: Long-term Effects
Status:
Recruiting
Trial end date:
2025-07-15
Target enrollment:
Participant gender:
Summary
This study will evaluate the effect of semaglutide on eating behavior, appetite
(hunger/fullness), and food liking in the long-term, as compared to placebo. All participants
will receive lifestyle modification (diet and exercise) counseling, and will be prescribed
the FDA-approved weight loss medication, semaglutide, or placebo (an inactive saline
solution) for 72 weeks.